Skip to main content English

Drittmittelprojekte-Detailseite

Ketamine treatment in patients with schizophrenia for depression and mechanisms of action in a DISC1 mouse model

Source of funding: Medical Neuroscience Cluster
Head: Keimpema, Erik , Dr.
Funding: Medical University of Vienna
Period: 01.01.2024 - 01.01.2026